JAKARTA: Indonesia signed an agreement with China’s Sinovac Biotech Ltd for 50 million doses of a Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.
Sinovac would ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement. Beijing-based Sinovac also granted priority access for bulk supply to Indonesia until the end of 2021.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!